CCCC · ISSUER CIK 1662579
C4 Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 3 C4 Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202616:43 | Oct 1, 2026 | CCCC | Director | A · Grant | $3.14 | +3,662 | 75,612 | +5% | $11K | ||
| Oct 2, 202616:43 | Oct 1, 2026 | CCCC | Director | A · Grant | $3.14 | +4,618 | 79,471 | +6% | $15K | ||
| Sep 21, 202616:24 | Sep 18, 2026 | CCCC | Chief Financial Officer | M · Exercise | — | +6,250 | 385,098 | +2% | — | ||
| Sep 21, 202616:24 | Sep 18, 2026 | CCCC | Chief Financial Officer | F · Tax | $3.39 | −2,775 | 382,323 | -1% | $9K |